NCATS gives priority to resources and projects that catalyze innovation in translational science and enable the biomedical research community to realize the potential of science to deliver tangible improvements in human health. Individual consideration is given to each grant application. Final award decisions are based on a variety of criteria, including scientific merit, program relevance and balance, responsiveness to the Center’s priorities, and availability of funds.
Choose a fiscal year:
Fiscal Year 2021
NCATS does not yet have an appropriation. The Center is operating under a continuing resolution (CR) through Dec. 11, 2020.
Competing Awards
- We are planning to fund new competing awards with no percentage reduction in the approved funding level. We will reduce for salaries that exceed the salary cap.
- Salaries are limited to the levels published on Salary Cap and Stipends.
- No inflationary increases in calculating future years.
Noncompeting Awards
- We are planning to fund noncompeting continuation awards at the level from the Notice of Award with no percentage reduction.
- Salaries are limited to the levels published on Salary Cap and Stipends.
Fiscal Year 2020
The Further Consolidated Appropriations Act, 2020 (P.L. 116-94) was signed into law on December 20, 2019. Applicants and award recipients should follow all applicable notices, including: NOT-OD-20-065 (Guidance on Salary Limitation for Grants and Cooperative Agreements), NOT-OD-20-066 (Notice of Legislative Mandates in Effect), NOT-OD-20-068 (Notice of Fiscal Policies in Effect), and NOT-OD-20-070 (Ruth L. Kirschstein National Research Service Award (NRSA) Stipends, Tuition/Fees and Other Budgetary Levels).
Competing Awards
Competing grants will be funded at levels and duration based on programmatic and Office of Grants Management funding recommendations.
Non-Competing Awards
NCATS non-competing research grants will be awarded at 100 percent of the committed level.
Fiscal Year 2019
The Department of Defense and Labor, Health and Human Services, and Education Act, 2019 and Continuing Appropriations Act, 2019 was signed into law on September 28, 2018. Applicants and award recipients should follow the legislative mandates, salary limitations, and NRSA funding levels published in NOT-OD-19-031.
Competing Awards
Competing grants were funded at levels and duration based on programmatic and Office of Grants Management funding recommendations.
Non-Competing Awards
NCATS non-competing research grants were awarded at 100 percent of the committed level.
Fiscal Year 2018
On March 23, 2018, NIH received an appropriation for FY 2018. NCATS will update its financial management plan as more information becomes available.
Fiscal Year 2017
NOT-OD-17-086 provides guidance about the NIH Fiscal Operations for FY 2017 and implements the Consolidated Appropriations Act, 2017 (Public Law 115-31), signed by President Trump on May 5, 2017.
Competing Awards
Competing grants were funded at levels and duration based on programmatic and Office of Grants Management funding recommendations.
Non-Competing Awards
NCATS non-competing research grants were awarded at 100 percent of the committed level.
Non-competing research awards previously issued in fiscal year 2017 at 90 percent of the committed level were revised to restore funds to the committed level.
Ruth L. Kirschstein National Research Service Awards will continue to be awarded under the provisions of NOT-OD-17-003, published on Dec. 15, 2016, and NOT-OD-17-084, published on June 27, 2017, until further notice.
Legislative mandates announced in NOT-OD-17-075, published on June 9, 2017 remain in effect.
Salaries remain prohibited above Executive Level II under grants and other extramural mechanisms as announced in NOT-OD-17-087, published on July 3, 2017. Executive Level II increased from $185,100 to $187,000, effective Jan. 8, 2017.
Fiscal Year 2016
Competing Awards
Competing grants were funded at levels based on programmatic and Office of Grants Management funding recommendations.
Non-Competing Awards
NCATS non-competing grants were awarded at 100 percent of the committed level.
Ruth L. Kirschstein National Research Service Awards will continue to be awarded under the provisions of NOT-OD-15-048 until further notice.
Non-competing awards previously issued in fiscal year 2016 under the continuing resolution at 90 percent of the committed level were revised to restore funds to the committed level.
Legislative mandates in effect for fiscal year 2016 are listed in NOT-OD-16-044, published on Dec. 25, 2015, and corrected in NOT-OD-16-048, published on Dec. 30, 2015.
Salaries remain prohibited above Executive Level II under grants and other extramural mechanisms as announced in NOT-OD-16-045, published on Dec. 24, 2015; however, Executive Level II increased from $183,300 to $185,100, effective Jan. 10, 2016.
Fiscal Year 2015
Competing Awards
Competing grants were funded at levels based on programmatic and Office of Grants Management funding recommendations.
Non-Competing Awards
NCATS non-competing grants were awarded at 100 percent of the committed level with the exception of Discovering New Therapeutic Uses for Existing Molecules program grants, which may be awarded at a reduction of no more than 3 percent from the committed level. Future year commitments will remain unchanged.
Ruth L. Kirschstein National Research Service Awards were awarded under the provisions of NOT-OD-15-048, that is, at the requested/committed level while increasing the undergraduate and graduate student stipends by 2 percent on average. Entry-level postdoctoral stipends were increased to $42,840.
Non-competing awards previously issued in fiscal year 2015 under the continuing resolution at 90 percent of the committed level were revised to restore funds to the committed level.
Salaries remain prohibited above Executive Level II under grants and other extramural mechanisms; however, Executive Level II was increased by 1 percent from $181,500 to $183,300, effective Jan. 11, 2015.
Fiscal Year 2014
Competing Awards
Competing grants were funded at levels based on programmatic and Office of Grants Management funding recommendations.
Non-Competing Awards
Non-competing grants (other than Centers) were awarded at a reduction of no more than 3 percent from the committed level. Non-competing Center grants were awarded at a reduction of no more than 5 percent from the committed level. Future year commitments remained unchanged. This policy applied to all grants except Ruth L. Kirschstein National Research Service Awards, which increased undergraduate and graduate student stipends by 2 percent. Entry-level postdoctoral stipends were increased to $42,000 with 4 percent increases between the individual levels of experience.
Non-competing awards previously issued in fiscal year 2014 under the continuing resolution at 90 percent of the committed level were revised to restore funds to the committed level.
Salaries remained prohibited above Executive Level II under grants and other extramural mechanisms; however, Executive Level II was increased by 1 percent from $179,700 to $181,500, effective Jan. 12, 2014.
Fiscal Year 2013
Competing Awards
NIH operated at a reduced program level for fiscal year 2013. As a result, NCATS issued competing grants at appropriate levels based on programmatic and Office of Grants Management funding recommendations.
Non-Competing Awards
Non-competing grants — excluding Ruth L. Kirschstein National Research Service Awards, institutional career awards, conference grants and Small Business Innovation Research/Small Business Technology Transfer grants — were awarded at a reduction of no more than 6–8 percent from the committed level. Future year commitments remained unchanged. Non-competing awards previously issued in fiscal year 2013 under the continuing resolution were revised to restore funds to the appropriate level based on the fiscal year 2013 funding policy.
